Company:  EMERGENT BIOSOLUTIONS INC ... (EBS)
Form Type:  4
Filing Date:  11/8/2018 
CIK:  0001367644 
Address:  400 PROFESSIONAL DR, SUITE 400 
City, State, Zip:  GAITHERSBURG, Maryland 20879 
Telephone:  240-631-3200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$43.70  
Change: 
-0.54 (-1.22%)  
Trade Time: 
12:33 PM EST  
Market Cap: 
$2.25B
Trade EBS now with 

© 2019  
Description of Business
Emergent BioSolutions Inc. is a global life sciences company focused on providing to civilian and military populations a portfolio of innovative preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats ("PHTs," each a "PHT"). We were incorporated in the State of Michigan in May 1998 and subsequently reorganized as a Delaware corporation in June 2004. We are focused on the following four distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives ("CBRNE"); emerging infectious diseases ("EID"); travelers' diseases; and opioids. We have a product portfolio of eleven products (vaccines, antibody therapeutics, and drug-device combination products) that generate a majority of our revenue.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES